Apigenin and Carbenoxolone Co-Treatment Induces Potent Cytotoxicity in CAL-27 Oral Squamous Cell Carcinoma: A Morphological and Dose-Response Study

Combined Anticancer Effects of Apigenin and Carbenoxolone

Authors

  • Amna Bibi Ziauddin University, Karachi, Pakistan
  • Rehan Imad Ziauddin University, Karachi, Pakistan
  • Shazia Hashmat Ziauddin University, Karachi, Pakistan
  • Abdul Hameed Ziauddin University, Karachi, Pakistan
  • Alfred Henry Ziauddin University, Karachi, Pakistan

Keywords:

Apigenin, Carbenoxolone, Cytotoxicity, Combination therapy, Cytology, Oral squamous cell carcinoma

Abstract

Background: Oral squamous cell carcinoma is a major health burden across the globe due to its widespread incidence, limited effective therapeutics, and high recurrence rates. Natural and synthetic compounds such as Apigenin (API) and Carbenoxolone (CBX) have shown significant antitumor potential against various cancer types. The current study aimed to evaluate the anti-proliferative potential of API and CBX, alone or in combination in the CAL-27 oral cancer cell line.

Methods: MTT assay was used to analyze the cytotoxic potential of API, CBX, and their combination in the CAL-27 cell line. Differential Interference Contrast (DIC) microscopy was performed to identify alterations in cellular morphology after treatment.

Results: The half maximal inhibitory concentrations for API and CBX were calculated as 50 µM and 200 µM respectively.  Significantly greater inhibition of 86.37% (p-value <0.001) was observed after combination treatment in the CAL-27 cell line. Microscopic examination revealed cell death, cell shrinkage and detachment, and membrane damage in combination-treated cells compared with control and single agent treatment groups.

Conclusion: Treatment with API and CBX exhibited decreased cell viability, and their combination further increased antiproliferative effects in CAL-27 cells, suggesting that these compounds in combination are potential candidates for anticancer therapy in OSCC.

 

Author Biographies

Amna Bibi, Ziauddin University, Karachi, Pakistan

Research Scholar, Department of Physiology

Rehan Imad, Ziauddin University, Karachi, Pakistan

Assistant Professor, Department of Molecular Medicine

Shazia Hashmat, Ziauddin University, Karachi, Pakistan

Associate Professor, Department of Physiology

Abdul Hameed, Ziauddin University, Karachi, Pakistan

Associate Professor, Department of Molecular Medicine

Alfred Henry, Ziauddin University, Karachi, Pakistan

Research Scholar, Department of Molecular Medicine

References

Nokovitch L, Maquet C, Frédéric Crampon, Ihsène Taihi, Roussel LM, Rais Obongo, et al. Oral Cavity Squamous Cell Carcinoma Risk Factors: State of the Art. Oral Cavity Squamous Cell Carcinoma Risk Factors: State of the Art [Internet]. 2023 May 3;12(9):3264. Available from: https://doi.org/10.3390/jcm12093264

Deshmukh V, Shekar K. Oral Squamous Cell Carcinoma: Diagnosis and Treatment Planning. Oral and Maxillofacial Surgery for the Clinician [Internet]. 2021;12(9):1853–67. Available from: https://doi.org/10.1007/978-981-15-1346-6_81

Givony S. Oral squamous cell carcinoma (OSCC) an overview . Journal of Medical Sciences. 2020;8(13):67–74.

Kalogirou EM, Tosios KI, Christopoulos PF. The Role of Macrophages in Oral Squamous Cell Carcinoma. Frontiers in Oncology [Internet]. 2021 Mar 18;11:611115. Available from: https://doi.org/10.3389%2Ffonc.2021.611115

Coletta RD, Yeudall WA, Salo T. Grand Challenges in Oral Cancers. Frontiers in Oral Health [Internet]. 2020 Jun 9;1. Available from: https://doi.org/10.3389/froh.2020.00003

Miranda-Filho A, Bray F. Global patterns and trends in cancers of the lip, tongue and mouth. Oral Oncology [Internet]. 2020 Mar [cited 2020 Feb 10];102:104551. Available from: https://doi.org/10.1016/j.oraloncology.2019.104551

Constantinescu T, Lungu CN. Anticancer Activity of Natural and Synthetic Chalcones. International Journal of Molecular Sciences [Internet]. 2021 Oct 20;22(21):11306. Available from: https://doi.org/10.3390/ijms222111306

Imran M, Aslam Gondal T, Atif M, Shahbaz M, Batool Qaisarani T, Hanif Mughal M, et al. Apigenin as an anticancer agent. Phytotherapy Research [Internet]. 2020 Feb 14;34(8):1812–28. Available from: https://doi.org/10.1002/ptr.6647

Rahmani AH, Alsahli MA, Almatroudi A, Almogbel MA, Khan AA, Anwar S, et al. The Potential Role of Apigenin in Cancer Prevention and Treatment. Molecules [Internet]. 2022 Sep 16;27(18):6051. Available from: https://doi.org/10.3390/molecules27186051

Naponelli V, Maria Teresa Rocchetti, Mangieri D. Apigenin: Molecular Mechanisms and Therapeutic Potential against Cancer Spreading. International Journal of Molecular Sciences [Internet]. 2024 May 20;25(10):5569–9. Available from: https://doi.org/10.3390/ijms25105569

Sharma S, Saini A, Nehru B. Neuroprotective effects of carbenoxolone against amyloid-beta 1–42 oligomer-induced neuroinflammation and cognitive decline in rats. NeuroToxicology [Internet]. 2021 Mar [cited 2021 Nov 24];83:89–105. Available from: https://doi.org/10.1016/j.neuro.2020.12.015

Zhang L ζ, Fan Z, Wang L, Liu L, Li X, Li L, et al. Carbenoxolone decreases monocrotaline induced pulmonary inflammation and pulmonary arteriolar remodeling in rats by decreasing the expression of connexins in T lymphocytes. International Journal of Molecular Medicine [Internet]. 2019 Nov 13 [cited 2025 Nov 24];45(1):81–92. Available from: https://doi.org/10.3892/ijmm.2019.4406

Salvi M, Fiore C, Battaglia V, Palermo M, Armanini D, Toninello A. Carbenoxolone Induces Oxidative Stress in Liver Mitochondria, Which Is Responsible for Transition Pore Opening. Endocrinology [Internet]. 2005 May 1 [cited 2020 Dec 14];146(5):2306–12. Available from: https://doi.org/10.1210/en.2004-1128

Song Z, Zhao C, Yan J, Jiang D, Jia G. Carbenoxolone Disodium Suppresses the Migration of Gastric Cancer By Targeting HDAC6. Future Medicinal Chemistry [Internet]. 2023 Feb;15(4):333–44. Available from: https://doi.org/10.4155/fmc-2022-0246

Tamborini M, Valentino Ribecco, Elisabetta Stanzani, Sironi A, Tambalo M, Franzone D, et al. Extracellular Vesicles Released by Glioblastoma Cancer Cells Drive Tumor Invasiveness via Connexin-43 Gap Junctions. Neuro-Oncology [Internet]. 2025 Jan 30 [cited 2025 Sep 14];27(11):2843–60. Available from: https://doi.org/10.1093/neuonc/noaf013

Lai J, Fang C, Zhang G, Shi C, Yu F, Gu W, et al. Novel Prognostic Model Construction of Tongue Squamous Cell Carcinoma Based on Apigenin-Associated Genes. Frontiers in Bioscience-Landmark [Internet]. 2024 Feb 6 [cited 2026 May 16];29(2):65. Available from: https://doi.org/10.31083/j.fbl2902065

Kim TW, Lee HG. Apigenin Induces Autophagy and Cell Death by Targeting EZH2 under Hypoxia Conditions in Gastric Cancer Cells. International Journal of Molecular Sciences [Internet]. 2021 Dec 15;22(24):13455. Available from: https://doi.org/10.3390/ijms222413455

Pei C, Zhang J, Li J, Zhou D. Apigenin suppresses the low oxaliplatin-induced epithelial-mesenchymal transition in oral squamous cell carcinoma cells via LINC00857. Translational Cancer Research [Internet]. 2024 May;13(5):2164–74. Available from: https://doi.org/10.21037/tcr-23-2335

Moosavi M, S Moasses Ghafary, I Asvadi-Kermani, H Hamzeiy, Rahmati M, Ahmadi A, et al. Carbenoxolone induces apoptosis and inhibits survivin and survivin-ΔEx3 genes expression in human leukemia K562 cells. DARU Journal of Pharmaceutical Sciences [Internet]. 2026;19(6):455. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC3436083/

Tsuruda T, Kodama M, Nakayama KI. Small Cell Lung Cancer Establishes a Metabolic Autocrine Mechanism Through Active Extracellular ATP Transport. Cancer Science [Internet]. 2026 Mar 2;117(5):1333–45. Available from: https://doi.org/10.1111/cas.70350

EDWARDS E, SCHENONE D, SIVAGNANALINGAM U, PERRY S, MULLEN CA. GAP JUNCTION FUNCTION IS ESSENTIAL FOR SURVIVAL OF ACUTE LYMPHOBLASTIC LEUKEMIA CELLS. Experimental Oncology [Internet]. 2024 Oct 9 [cited 2026 May 16];46(2):110–8. Available from: https://doi.org/10.15407/exp-oncology.2024.02.110

Chen YH, Wu JX, Yang SF, Yang CK, Chen TH, Hsiao YH. Anticancer Effects and Molecular Mechanisms of Apigenin in Cervical Cancer Cells. Cancers [Internet]. 2022 Apr 4;14(7):1824. Available from: https://doi.org/10.3390/cancers14071824

Fossatelli L, Zaira Maroccia, Fiorentini C, Massimo Bonucci. Resources for Human Health from the Plant Kingdom: The Potential Role of the Flavonoid Apigenin in Cancer Counteraction. International journal of molecular sciences [Internet]. 2023 Dec 23;25(1):251–1. Available from: https://doi.org/10.3390/ijms25010251

Langlois S, Marie-Eve St-Pierre, Holland SH, Xiang X, Freeman E, Mohamed H, et al. Inhibition of PANX1 Channels Reduces the Malignant Properties of Human High-Risk Neuroblastoma. Journal of Cancer [Internet]. 2023 Jan 1;14(5):689–706. Available from: https://doi.org/10.7150/jca.79552

Liang YC, Zhong Q, Ma RH, Ni ZJ, Thakur K, Mohammad Rizwan Khan, et al. Apigenin inhibits migration and induces apoptosis of human endometrial carcinoma Ishikawa cells via PI3K-AKT-GSK-3β pathway and endoplasmic reticulum stress. Journal of Functional Foods [Internet]. 2022 Jul 1 [cited 2024 Mar 11];94. Available from: https://doi.org/10.1016/j.jff.2022.105116

Wu J, Zhang D, Liu H, Li J, Li T, Wu J, et al. Neuroprotective effects of apigenin on retinal ganglion cells in ischemia/reperfusion: modulating mitochondrial dynamics in in vivo and in vitro models. Journal of Translational Medicine [Internet]. 2024 May 13;22(1). Available from: https://doi.org/10.1186/s12967-024-05260-1

Buckley C, Zhang X, Wilson C, McCarron JG. Carbenoxolone and 18β‐glycyrrhetinic acid inhibit inositol 1,4,5‐trisphosphate‐mediated endothelial cell calcium signalling and depolarise mitochondria. British Journal of Pharmacology [Internet]. 2021 Jan 17 [cited 2023 Dec 14];178(4):896–912. Available from: https://doi.org/10.1111/bph.15329

Downloads

Published

2026-04-30